StonvexLoading…
StonvexStonvexStonvexCore line items from DUOL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $301.62M | $291.97M | $1.04B | $754.72M | $483.01M |
Operating Income | Not available | $44.53M | $135.57M | $92.12M | $56.96M |
Net Income | Not available | $43.46M | $414.06M | $372.11M | $79.92M |
EPS (Diluted) | $0.60 | $0.89 | $8.57 | $7.63 | $1.64 |
Total Assets | Not available | $2.06B | $1.99B | $1.89B | $1.54B |
Total Liabilities | Not available | $666.23M | $645.18M | $578.10M | $565.53M |
Cash & Equivalents | Not available | $1.14B | $1.04B | $1.01B | $976.23M |
Free Cash Flow OCF − CapEx | Not available | $150.64M | $369.73M | $273.18M | $193.80M |
Shares Outstanding | Not available | 48.99M | 48.31M | 48.77M | 48.77M |